Dapiglutide not checked

Zealand Pharma · ZP7570 · GLP-1/GLP-2 agonist

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
3 in total · 3 in the EU
Targets
—
None known yet

What this is

How it works
Copies GLP-1 or GLP-2, gut hormones. GLP-1 copies (like Ozempic) lower appetite and blood sugar; GLP-2 copies help the gut absorb food.-glutide: GLP analogues WHO name stem
How it’s given
“13 once-weekly subcutaneous injections in Part 1. 28 once-weekly subcutaneous injections in Part 2.”In the company’s words, NCT06000891 on ClinicalTrials.gov
Tested for
Safety and Tolerability, Overweight and Obesity
Main trialPhase 1
“The trial is a Phase 1, single-centre, randomised and double-blind within cohorts, placebo-controlled, sequential multiple ascending dose trial including three cohorts in Part 1 in a semi-parallel design and one cohort in Part 2 in overweight and obese but otherwise healthy subjects, randomised to ZP7570 or placebo within each cohort where the observational period is 18 weeks for Part 1 and 28 weeks for Part 2. All subjects will be dosed for 13 weeks in Part 1 and for 28 weeks in Part 2 with ascending weekly doses of ZP7570 at dose levels with corresponding volume of placebo.”In the company’s words, NCT06000891 on ClinicalTrials.gov
Other names
ZP7570 · GLP-1/GLP-2 agonist

Other drugs for Safety and Tolerability

All 158 drugs for Safety and Tolerability

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials3

TrialPhaseCompletesWhat it tests
Phase 1Terminated 11 Feb 2025 A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
Phase 1Completed 12 Apr 2025 A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide
Phase 2Ended not given Dapiglutide for the treatment of obesity (DREAM): a randomised, double-blind, placebo-controlled, investigator-initiated trial
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Dapiglutide

Following is part of Solo: you see every change to Dapiglutide the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in